Image enhanced endoscopy and molecular biomarkers vs Seattle protocol to diagnose dysplasia in Barrett's esophagus.

[1]  S. Killcoyne,et al.  Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot , 2022, The Lancet. Oncology.

[2]  A. Bass,et al.  Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia , 2020, medRxiv.

[3]  S. Killcoyne,et al.  Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study , 2020, EBioMedicine.

[4]  L. Wernisch,et al.  Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low-Grade Dysplasia in Barrett's Esophagus , 2019, Clinical and translational gastroenterology.

[5]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[6]  Jan G P Tijssen,et al.  Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel , 2014, Gut.

[7]  M. Aalders,et al.  Fluorescence imaging for the detection of early neoplasia in Barrett’s esophagus: old looks or new vision? , 2014, European journal of gastroenterology & hepatology.

[8]  J. Tijssen,et al.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. , 2014, JAMA.

[9]  Sharmila Anandasabapathy,et al.  In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). , 2014, Gastrointestinal endoscopy.

[10]  L. Wernisch,et al.  The combination of auto fl uorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett ’ s oesophagus , 2014 .

[11]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[12]  Vikas Singh,et al.  Novel Probe-Based Confocal Laser Endomicroscopy Criteria and Interobserver Agreement for the Detection of Dysplasia in Barrett's Esophagus , 2011, The American Journal of Gastroenterology.

[13]  Jashanpreet Singh,et al.  The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.

[14]  J. Goldblum,et al.  Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. , 2011, Gastroenterology.

[15]  Michael B Wallace,et al.  Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. , 2011, Gastrointestinal endoscopy.

[16]  Erik Schoon,et al.  Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. , 2011, Gastrointestinal endoscopy.

[17]  H. Welch,et al.  Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[18]  P. Rabinovitch,et al.  Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy , 2010, British Journal of Cancer.

[19]  A. Neugut,et al.  Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  A. Ivens,et al.  Comparative Expression Profiling of Leishmania: Modulation in Gene Expression between Species and in Different Host Genetic Backgrounds , 2009, PLoS neglected tropical diseases.

[21]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[22]  I. Russell,et al.  Effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET) , 2009, BMJ : British Medical Journal.

[23]  L. Lovat,et al.  Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance , 2006, Clinical Cancer Research.

[24]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[25]  M. Dixon.  Gastrointestinal epithelial neoplasia: Vienna revisited , 2002, Gut.